Th cell development and regulation in experimental cutaneous leishmaniasis

Chemical Immunology

Volumn 63, Issue , 1996, Pages 98-114

  Scott, Phillip ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL GROWTH; CELL MATURATION; HELPER CELL; IMMUNE RESPONSE; IMMUNOMODULATION; MACROPHAGE; PRIORITY JOURNAL; REVIEW; SCHISTOSOMA MANSONI; SKIN LEISHMANIASIS;

EID: 0029937829     PISSN: 10150145     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319481     Document Type: Review

References (72)

1. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL: Two types of murine helper T cell clone: Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;2348-2357.
2. Scott P, Natovitz P, Coffman RL, Pearce E, Sher A: Immunoregulation of cutaneous leishmaniasis: T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J Exp Med 1988;168:1675-1684.
3. Liew FY, Hale C, Howard JG: Immunologic regulation of experimental cutaneous leishmaniasis. V. Characterization of effector and specific suppressor T cells. J Immunol 1982;128:1917-1922.
4. Turk JL, Bryceson ADM Immunologic phenomena in leprosy and related diseases Adv Immunol 1971;13:209-266.
5. Neva FA, Sacks DL: Leishmaniasis New York, McGraw Hill. 1990.
6. Bryceson ADM, Bray RS, Dumonde DC: Experimental cutaneous leishmaniasis. IV. Selective suppression of cell mediated immunity during the response of guinea pigs to infection with Leishmania enriettii. Clin Exp Immunol 1974;16:189-202.
7. Poulter LW: Mechanisms of immunity to leishmaniasis I Evidence for a changing basis of protection in self-limiting disease Clin Exp Immunol 1980;39:14-26.
8. Preston PM, Carter RL, Leuchars E, Davies AJS, Dumonde DC: Experimental cutaneous leishmaniasis III Effects of thymectomy on the course of infection of CBA mice with Leishmania tropica. Clin Exp Immunol 1972;10:337-357.
9. Weintraub J, Weinbaum FI: The effect of BCG on experimental cutaneous leishmaniasis in mice. J Immunol 1977;118:2288-2290.
10. Preston PM, Behbehani K, Dumonde DC: Experimental cutaneous leishmaniasis. VI. Anergy and allergy in the cellular immune response during non-healing infection in different strains of mice. J Clin Lab Immunol 1978;1:207-219
11. Coffman RL, Chatelain R, Leal LM, Varkila K: Leishmania major infection in mice: A model system for the study of CD4+ T-cell subset differentiation. Res Immunol 1991;142:36-40.
12. Scott P: The role of Th1 and Th2 cells in experimental cutaneous leishmaniasis. Exp Parasitol 1989; 68:369-372.
13. Locksley RM, Scott P: Helper T-cell subsets in mouse leishmaniasis: Induction, expansion and effector function. Immunol Today 1991;12:A58-A61.
14. Liew FY: Functional heterogeneity of CD4+ T cells in leishmaniasis. Immunol Today 1989;10 40-45.
15. Gollob KJ, Coffman RL: A minority subpopulation of CD4+ T cells directs the development of naive CD4+ T cells into IL-4-secreting cells. J Immunol 1994;152:5180-5188.
16. Howard JG: Immunological regulation and control of experimental leishmaniasis. Int Rev Exp Pathol 1986;28:79-116.
17. Howard JG, Hale C, Liew FY: Immunologic regulation of experimental cutaneous leishmaniasis. IV: Prophylactic effect of sublethal irradiation as a result of abrogation of suppressor T cell generation in mice genetically susceptible to Leishmania tropica J Exp Med 1981;153:557-568.
18. Heinzel FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM: Reciprocal expression of interferon gamma or IL-4 during the resolution or progression of murine leishmaniasis: Evidence for expansion of distinct helper T cell subsets. J Exp Med 1989;169:59-72.
19. Heinzel FP, Sadick MD, Mutha SS, Locksley RM Production of IFN-γ, IL-2, IL-4 and IL-10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc Natl Acad Sci USA 1991;88:7011-7016.
20. Scott P: Selective activation of CD4+ T cell subsets Curr Opin Immunol 1993;5:391-397.
21. Coffman RL, Varkila K, Scott P, Chatelain R: Role of cytokines in the differentiation of CD4+ T-cell subsets in vivo. Immunol Rev 1991;123:189-207.
22. Sadick MD, Heinzel FP, Holaday BJ, Pu RT, Dawkins RS, Locksley RM: Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody: Evidence for a T cell-dependent, interferon gamma-independent mechanism. J Exp Med 1990;171:115-127.
23. Chatelain R, Varkila K, Coffman RL: IL-4 induces a Th2 response in Leishmania major-infected mice. J Immunol 1992;148 1182-1187.
24. Belosevic M, Finbloom DS, Van Der Meide PH, Slayter MV, Nacy CA: Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major J Immunol 1989;143:266-274.
25. Scott P: IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. J Immunol 1991;147:3149-3155.
26. Heinzel FP, Schoenhaut DS, Rerko RM, Rosser LE, Gately MK: Recombinant interleukin 12 cures mice infected with Leishmania major J Exp Med 1993;177 1505-1509.
27. Scharton-Kersten T, Afonso LCC, Wysocka M, Trinchieri G, Scott P: IL-12 is required for NK cell activation and subsequent Th1 cell development in experimental leishmaniasis. J Immunol 1995; 154:5320-5330.
28. Reiner SL, Zheng S, Wang Z-E, Stowring L, Locksley RM: Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection. J Exp Med 1994;179:447-456
29. Bendelac A, Killeen N, Littman DR, Schwartz RH: A subset of CD4+ thymocytes selected by MHC class I molecules. Science 1994;262:1774-1778.
30. Reiner SL, Wang Z-E, Hatam F, Scott P, Locksley RM: Common lineage of Th1 and Th2 subsets in leishmaniasis. Science 1993;259:1457-1460.
31. Lohoff M, Steinert M, Weiss A, Rollinghoff M, Balderas RS. Theofilopoulos AN: V beta gene repertoires in T cells expanded in local self-healing and lethal systemic murine cutaneous leishmaniasis. Eur J Immunol 1994;24:492-495.
32. Shankar AH, Titus RG: T cell and non-T cell compartments can independently determine resistance to Leishmania major. J Exp Med 1995;181:845-855.
33. Hsieh C-S, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM: Development of Th1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 1993;260:547-549.
34. Sypek JP, Chung CL, Mayor SEH, Subramanyam JM, Goldman SJ, Sieburth DS, Wolf SF, Schaub RG: Resolution of cutaneous leishmaniasis. Interleukin 12 initiates a protective Th1 immune response. J Exp Med 1993;177:1797-1802.
35. Vieira LQ, Hondowicz BD, Afonso LCC, Wysocka M, Trinchieri G, Scott P: Infection with Leishmania major induces interieukin-12 production in vivo. Immunol Lett 1994;40:157-161.
36. Descoteaux A, Maltashewski G, Turco SJ: Inhibition of macrophage protein kinase C-mediated protein phosphorylation by Leishmania donovani lipophosphoglycan. J Immunol 1992;149:3008-3015.
37. Scott P. IL-12: Initiation cytokine for cell-mediated immunity. Science 1993;260:496-497.
38. Afonso LCC, Scharton TM, Vieira LQ, Wysocka M, Trinchieri G, Scott P: The adjuvant effect of interleukin-12 in a vaccine against Lishmania major. Science 1994;263:235-237.
39. Wang Z-E, Reiner SL, Zheng S, Dalton DK, Locksley RM: CD4+ effector cells default to the Th2 pathway in interferon-γ-deficient mice infected with Leishmania major. J Exp Med 1994;179 1367-1371.
40. Swihart K, Furth U, Messmer N, Hug K, Behin R, Huang S, Del Giudice G, Aguet M, Louis JA: Mice from a genetically resistant background lacking the interferon γ receptor are susceptible to infection with Leishmania major but mount a polarized T helper cell 1-type CD4+ T cell response. J Exp Med 1995;181:961-971.
41. Heinzel FP, Rerko RM, Hatam R, Locksley RM: IL-2 is necessary for the progression of leishmaniasis in susceptible murine hosts. J Immunol 1993;150:3924-3931.
42. Titus RG, Sherry B, Cerami A: Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis J Exp Med 1989;170:2097-2103.
43. Barral-Netto M, Barrai A, Brownell CE, Skeiky YAW, Ellingsworth LR, Twardzik DR, Reed SG: Transforming growth factor-β in leishmanial infection. A parasite escape mechanism. Science 1992; 257:545-548
44. Stenger S, Thuring H, Rollinghoff M, Bogdan C: Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J Exp Med 1994;180:783-793.
45. Janeway CA, Jr: The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol Today 1992;13:11-16.
46. Romagnani S: Induction of Th1 and Th2 responses: A key role for the 'natural' immune response? Immunol today 1992;13:379-383.
47. Scharton TM, Scott P: Natural killer cells are a source of IFN-γ that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. J Exp Med 1993; 178:567-577.
48. Hayakawa K, Hardy RR: Murine CD4+ T-cell subsets. Immunol Rev 1991;123:145-168.
49. Sher A, Coffman RL: Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu Rev Immunol 1992;10:385-409.
50. Butcher BA, Sklar LA, Seamer LC, Glew RH: Heparin enhances the interaction of infective Leishmania donovani promastigotes with mouse peritoneal macrophages: A fluorescence flow cytometric analysis. J Immunol 1992;148:2879-2886.
51. Flesch IEA, Hess JH, Huang S, Aguet M, Rothe J, Bluethmann H, Kaufmann SHE: Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon γ and tumor necrosis factor α. J Exp Med 1995;181:1615-1621
52. Scott P, Scharton T: Interactions between the innate and the acquired immune system following infection of different mouse strains with Leishmania major. Ann NY Acad Sci 1994;730:84-92.
53. Titus RG, Ceredig R, Cerottini JC, Louis JA: Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically-susceptible BALB/c mice. J Immunol 1985;135: 2108-2114.
54. Solbach W, Forber GK, Kammerer E, Bogdan C, Rollinghoff M: Suppressive effect of cyclosporin A on the development of Leishmania tropica-induced lesions in genetically susceptible BALB/c mice. J Immunol 1986;137:700-702.
55. Corry DB, Reiner SL, Linsley PS, Locksley RM: Differential effects of blockade of CD28-B7 on the development of Th1 or Th2 effector cells in experimental leishmaniasis. J Immunol 1994;153: 4142-4148.
56. Mitchell GF, Curtis JM, Scollay RG, Handman E: Resistance and abrogation of resistance to cutaneous leishmaniasis in reconstituted BALB/c nude mice. Aust J Exp Med Biol Sci 1981;59: 539-554.
57. Varkila K, Chatelain R, Leal LMCC, Coffman RL: Reconstitution of C.B-17 scid mice with BALB/ c T cells initiates a T helper type-1 response and renders them capable of healing Leishmania major infection. Eur J Immunol 1993;23:262-268.
58. Powrie F, Correa- Oliveira R, Mauze S, Coffman RL: Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. J Ecp Med 1994, 179 589-600.
59. Preston PM, Dumonde DC: Experimental cutaneous leishmaniasis. V. Protective immunity in subclinical and self-healing infections in the mouse. Clin Exp Immunol 1976;23:126-138.
60. Bretscher PA, Wei G, Menon JN, Bielefeldt-Ohmann H: Establishement of stable, cell-mediated immunity that makes 'susceptible' mice resistant to Leishmania major. Science 1992;257:539-542.
61. Parish CR: The relationship between homoral and cell-mediated immunity. Transplant Rev 1972; 13:35-66.
62. Liew FY, Hale C, Howard JG: Prophylactic immunization against experimental leishmaniasis. IV. Subcutaneous immunization prevents the induction of protective immunity against fatal Leishmania major infection J Immunol 1985;135:2095-2101.
63. Scott PA, Farrell JP: Experimental cutaneous leishmaniasis: Disseminated leishmaniasis in genetically susceptible and resistant mice. Am J Trop Med Hyg 1982;31:230-238.
64. Nabors G, Farrell JP: Site-specific immunity to Leishmania major in SWR mice. The site of infection influences susceptibility and expression of the anti-leishmanial immune response. Infect Immun 1994;62:3655-3662
65. Scott P, Kaufmann SHE: The role of T-cell subsets and cytokines in the regulation of infection. Immunol Today 1991;12:346-348
66. Kaye PM, Curry AJ, Blackwell JM: Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis. J Immunol 1991;146:2763-2770.
67. Afonso LCC, Scott P: Immune responses associated with the susceptibility of C57BL/10 mice to Leishmania amazonensis. Infect Immun 1993;61:2952-2959.
68. Holaday BJ, Sadick MD, Wang ZE, Reiner SL, Heinzel FP, Parslow TG, Locksley RM: Reconstitution of Leishmania immunity in severe combined immunodeficient mice using Th1- and Th2-like cell lines. J Immunol 1991;147:1653-1658.
69. Nabors GS, Afonso LCC, Farrell JP, Scott P. Switch from a type 2 to a type 1 T helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin 12 and Pentostam. Proc Natl Acad Sci USA 1995;92:3142-3146.
70. Mocci S, Coffman RL: Induction of a Th2 population from a polarized Leishmania-specific Th1 population by in vitro culture with IL-4. J Immunol 1995;154:3779-3787.
71. Hsieh C-S, Macatonia SE, O'Garra A, Murphy KM: T cell genetic background determines default T helper phenotype development in vitro. J Exp Med 1995;181:713-722.
72. Farrell JP, Kirkpatnck CE: Experimental cutaneous leishmaniasis. II. A possible role for prostaglandins in exacerbation of disease in Leishmania major-infected BALB/c mice. J Immunol 1987; 138:902-907.